Praxis Precision Medicines, Inc. uses a genetics-driven approach to develop potential best-in-class drugs for patients with central nervous system (CNS) disorders that are characterized by faulty ...
26 Oct 2021 12 Nov 2021 26 Nov 2021 Second interim dividend of 2.0 Sen per share tax-exempt for the financial year ended 31 December 2021 11 Nov 2021 25 Feb 2022 25 Mar 2022 08 Apr 2022 Third interim ...
Rights Mar 20, 2025 Mar 20, 2025 Nov 11, 2024 Rights ratio: 11 share for every 30 held at a price of Rs 10.0 Rights May 30, 2023 May 30, 2023 Mar 14, 2023 Rights ratio: 13 share for every 20 held at a ...
Visit a quote page and your recently viewed tickers will be displayed here.
Get the latest news and real-time alerts from Praxis Precision Medicines, Inc. (PRAX) stock at Seeking Alpha.
About Praxis Precision Medicines Inc. Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and ...
Will MGAFX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.
Will MPLAX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.
For best results, download and open this form in Adobe Reader. See General information for details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results